13FPulse
中
CO

CORT CORCEPT THERAPEUTICS INC

2026Q1 · CUSIP 218352102 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
348
Δ holders QoQ
-40
Breadth percentile
Top 96%
Whale holders
162
Δ whales
-5
Inst. holding value
$3.2B
New positions
70
Closed positions
110
Price momentum (1Q)
+39.1%
Put / Call
7/10

Breadth history (34 quarters)

2018Q1: holders=213 2018Q2: holders=215 2018Q3: holders=205 2018Q4: holders=220 2019Q1: holders=208 2019Q2: holders=180 2019Q3: holders=192 2019Q4: holders=203 2020Q1: holders=204 2020Q2: holders=223 2020Q3: holders=224 2020Q4: holders=228 2021Q1: holders=210 2021Q2: holders=199 2021Q3: holders=200 2021Q4: holders=208 2022Q1: holders=227 2022Q2: holders=223 2022Q3: holders=241 2022Q4: holders=246 2023Q1: holders=233 2023Q2: holders=227 2023Q3: holders=247 2023Q4: holders=274 2024Q1: holders=286 2024Q2: holders=287 2024Q3: holders=321 2024Q4: holders=369 2025Q1: holders=422 2025Q2: holders=422 2025Q3: holders=430 2025Q4: holders=388 2026Q1: holders=348 -53 -26.5 +0 +26.5 +53 162307452 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 11 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 2% -6.2% +0.4%
2024Q4 Top 10% +3.1% -3.3%
2024Q3 Top 8% +20.8% +44.6%
2023Q4 Top 20% +23.7% +51.8%
2023Q3 Top 8% -10.1% +15.0%
2022Q3 Top 7% -14.7% -8.7%
2022Q1 Top 9% +38.2% +36.5%
2020Q2 Top 18% +30.1% +99.2%

Options Sentiment

Put holders
7
QoQ: -7
Call holders
10
QoQ: -6

See methodology →

Fundamentals

PE (TTM)
261.6
EPS (TTM)
$0.35
EPS YoY
-69.6%
Revenue (TTM)
$0.8B
Revenue YoY
+12.2%
Net margin
6.2%
ROE
7.4%
Debt ratio
21.7%
FCF (TTM)
$120M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS 0.24 2022-09-30: EPS 0.30 2022-12-31: EPS 0.13 2023-03-31: EPS 0.14 2023-06-30: EPS 0.25 2023-09-30: EPS 0.28 2023-12-31: EPS 0.27 2024-03-31: EPS 0.25 2024-06-30: EPS 0.32 2024-09-30: EPS 0.41 2024-12-31: EPS 0.25 2025-03-31: EPS 0.17 2025-06-30: EPS 0.29 2025-09-30: EPS 0.16 2025-12-31: EPS 0.20 2026-03-31: EPS -0.30 0M 104M 208M $M -0.33 0.06 0.45 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 42 22 95 169 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.